"19515-818-52" National Drug Code (NDC)

NDC Code	19515-818-52
Package Description	10 SYRINGE in 1 CARTON (19515-818-52) > .5 mL in 1 SYRINGE (19515-818-41)
Product NDC	19515-818
Product Type Name	VACCINE
Proprietary Name	Flulaval Quadrivalent
Proprietary Name Suffix	2021/2022
Non-Proprietary Name	Influenza Virus Vaccine
Dosage Form	SUSPENSION
Usage	INTRAMUSCULAR
Start Marketing Date	20210702
End Marketing Date	20220630
Marketing Category Name	BLA
Application Number	BLA125163
Manufacturer	ID Biomedical Corporation of Quebec
Substance Name	INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Strength	15; 15; 15; 15
Strength Unit	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL